21 October 2015 - The U.S. Food and Drug Administration today approved Veltassa (patiromer) to treat patients with hyperkalaemia.

For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm468546.htm